[1] Hugh M R. The Tcl-mariner superfamily of transposons in animals. Journal of Insect Physiology, 1995, 41(2): 99-105.
[2] Bolton E C, Boeke J D. Transcriptional interactions between yeast tRNA genes, flanking genes and Ty ey Elements. A genomic point of view. Genome Research, 2003, 13(2): 254-63.
[3] Geurts A M, Yang Y, Clark K J, Liu G, Dupuy A J, Bell J B, Largaespada D A, Hackett P B. Gene transfer into genomes of human cells by the sleeping beauty transposon system. Molecular Therapy, 2003, 8: 108-117.
[4] Collier L S, Carlson C M, Ravimohan S, Dupuy A J, Largaespada D A. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature, 2005, 436: 272-276.
[5] Keng V W, Villanueva A, Chiang D Y, Dupuy A J, Ryan B J, Matise I, Silverstein K A, Sarver A, Starr T K, Akagi K, Tessarollo L, Collier L S, Powers S, Lowe S W, Jenkins N A, Copeland N G, Llovet J M, Largaespada D A. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nature Biotechnology, 2009, 27: 264-274.
[6] Rahrmann E P, Collier L S, Knutson T P, Doyal M E, Kuslak S L, Green L E, Malinowski R L, Roethe L, Akagi K, Waknitz M, Huang W, Largaespada D A, Marker P C. Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Research, 2009, 69: 4388-4397.
[7] Ohlfest J R, Frandsen J L, Fritz S, Lobitz P D, Perkinson S G, Clark K J, Nelsestuen G, Key N S, McIvor R S, Hackett P B, Largaespada D A. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood, 2005, 105(7): 2691-2698.
[8] Sheng D, Xiaohui W, Gang L, Min H, Yuan Z, Tian X. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell, 2005, 122(3): 473-483.
[9] Gloria S K, Anna K.Transthyretin mouse transgenes direct RFP expression or Cre-mediated recombination throughout the visceral endoderm. Genetics, 2009, 47(7): 447-455.
[10] Wei W, Chengyi L, Dong L, Zeming N, Tony C, David M, Wang X Z, Allan B, Pentao L. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proceedings of the National Academy of the Sciences of the United States of America, 2008, 105(27): 9290-9295.
[11] Lajos M, Marinee K L C, Eyayu B, Boris J, Namitha M, Abel A S , Dawid P G, Andrea S, Katja B, Janka M, Ling M, Ermira S K, Conny G, Diana P, Csaba M, Bradley F, Thierry V D, Zoltán I, Zsuzsanna I. Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nature Genetics, 2009, 41: 753 - 761.
[12] Qwens J B, Urschitz J, Stoytchev I, Dang N C, Stoytcheva Z, Belcaid M, Maragathavally K J, Coates C J, Segal D J, Moisyadi S. Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Research, 2012, 40(14): 6978-6991.
[13] Koichi K, Akihiro S and Noriko K. Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage. Proceedings of the National Academy of the Sciences of the United States of America, 2000, 97(21): 11403-11408.
[14] Kazuhide A, Maximiliano L S, Kanta M, Saori N, Tomoya K, Akihiro U, Yasuyuki K, Masahiko H, Koichi K. Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish. Proceedings of the National Academy of the Sciences of the United States of America, 2007, 105(4): 1255-1260.
[15] Mishima S. Tol2: a versatile gene transfer vector in vertebrates. Genome Biology, 2007, 8(Suppl 1): S1-S7.
[16] Yergeau D A, Clair M K, Emin K, Haiqing Z, Amy K S, Dan E W, Paul E M. Remobilization of Tol2 transposons in Xenopus tropicalis. Developmental Biology, 2010, 10: 1-17.
[17] Joni M, Lorna T, Adrian S, Koichi K, Yoshiko T, Helen M S, Michael J M. Efficient genetic modification and germ-line transmission of primordial germ cells using piggyBac and Tol2 transposons. Proceedings of the National Academy of the Sciences of the United States of America, 2012, 109(23): E1466-1472.
[18] Cédric F. The piggyBac transposon holds promise for human gene therapy. Proceedings of the National Academy of the Sciences of the United States of America, 2006, 103(41): 14981-14982.
[19] Xin H, Hong F G, Syam T, Yong C J, Emil M, Preetinder B, Qing C, Zheng J T, Yeong C K, Stephen C E, Xiao L W, San M W, Xianzheng Z. Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and PiggyBac transposons in human primary T cells. Molecular Therapy, 2010, 8(10): 1803-1813.
[20] Ivana G, Markus I, Lajos M, Eyayu B, Janka M, Andreas G, Koichi K, Wei C, Patricia R, Marinee K L C, Thierry V, Zsuzsanna I, Zoltán I. Comparative analysis of transposable element vector systems in human cells. Molecular Therapy, 2010, 18(6): 1200-1209.
[21] Francisco C P, Javier G, Inmaculada P, Valentín C. Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharmaceutical Research, 2011, 28(8): 1843-1858.
[22] Xue X, Huang X, Nodland S E, Mátés L, Ma L, Izsvák Z, Ivics Z, LeBien T W, Melvor R S, Wagner J E, Zhou X. Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood, 2009, 114(7): 1319-1330. |